ABL reveals logic behind partnerships, hopes to advance bispecific antibodies Sep. 29, 2020 By Gina Lee HONG KONG – Seongnam-Si, South Korea-based ABL Bio Inc. hopes to file IND applications for two solid tumor-focused bispecific antibodies.Read More
ABL reveals logic behind partnerships, hopes to advance bispecific antibodies Sep. 24, 2020 By Gina Lee HONG KONG – Seongnam-Si, South Korea-based ABL Bio Inc. hopes to file IND applications for two solid tumor-focused bispecific antibodies (BsAb), CEO Sang-hoon Lee, told the 2020 Bioplus Interphex Korea conference.Read More
